Y. Shi, Mechanisms of Caspase Activation and Inhibition during Apoptosis, Molecular Cell, vol.9, issue.3, pp.459-70, 2002.
DOI : 10.1016/S1097-2765(02)00482-3

J. Lieberman, Cell death and immunity: The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal, Nature Reviews Immunology, vol.3, issue.5, pp.361-70, 2003.
DOI : 10.1038/nri1083

B. Lowin, M. Hahne, C. Mattmann, and J. Tschopp, Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways, Nature, vol.370, issue.6491, pp.650-652, 1994.
DOI : 10.1038/370650a0

R. Locksley, N. Killeen, and M. Lenardo, The TNF and TNF Receptor Superfamilies, Cell, vol.104, issue.4, pp.487-501, 2001.
DOI : 10.1016/S0092-8674(01)00237-9

A. Chinnaiyan, K. O-'rourke, M. Tewari, and V. Dixit, FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis, Cell, vol.81, issue.4, pp.505-517, 1995.
DOI : 10.1016/0092-8674(95)90071-3

P. Schneider, M. Thome, K. Burns, J. Bodmer, K. Hofmann et al., TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-??B, Immunity, vol.7, issue.6, pp.831-837, 1997.
DOI : 10.1016/S1074-7613(00)80401-X
URL : http://doi.org/10.1016/s1074-7613(00)80401-x

M. Irmler, M. Thome, M. Hahne, P. Schneider, K. Hofmann et al., Inhibition of death receptor signals by cellular FLIP, Nature Jul, vol.10388, issue.6638, pp.190-195, 1997.

Q. Zhou, S. Snipas, K. Orth, M. Muzio, V. Dixit et al., Target Protease Specificity of the Viral Serpin CrmA: ANALYSIS OF FIVE CASPASES, Journal of Biological Chemistry, vol.272, issue.12, pp.7797-800, 1997.
DOI : 10.1074/jbc.272.12.7797

M. Tewari and V. Dixit, Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product, J Biol Chem Feb, vol.17270, issue.7, pp.3255-60, 1995.

C. Sprecher, K. Morgenstern, S. Mathewes, J. Dahlen, S. Schrader et al., Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors, J Biol Chem, vol.270, issue.1150, pp.29854-61, 1995.

C. Bird, V. Sutton, J. Sun, C. Hirst, A. Novak et al., Selective Regulation of Apoptosis: the Cytotoxic Lymphocyte Serpin Proteinase Inhibitor 9 Protects against Granzyme B-Mediated Apoptosis without Perturbing the Fas Cell Death Pathway, Molecular and Cellular Biology, vol.18, issue.11, pp.6387-98, 1998.
DOI : 10.1128/MCB.18.11.6387

M. Zhang, S. Park, Y. Wang, R. Shah, N. Liu et al., Serine Protease Inhibitor 6 Protects Cytotoxic T Cells from Self-Inflicted Injury by Ensuring the Integrity of Cytotoxic Granules, Immunity, vol.24, issue.4, pp.451-61, 2006.
DOI : 10.1016/j.immuni.2006.02.002

R. Annand, J. Dahlen, C. Sprecher, D. Dreu, P. Foster et al., Caspase-1 (interleukin-1??-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9, Biochemical Journal, vol.342, issue.3, pp.655-65, 1999.
DOI : 10.1042/bj3420655

J. Young, G. Sukhova, D. Foster, W. Kisiel, P. Libby et al., The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells, J Exp Med, vol.191191, issue.1599, pp.1535-441535, 2000.

M. Bots, L. Van-bostelen, M. Rademaker, R. Offringa, and J. Medema, Serpins prevent granzyme-induced death in a species-specific manner, Immunology and Cell Biology, vol.272, issue.1, pp.79-86, 2006.
DOI : 10.1083/jcb.200210158

O. Micheau, S. Lens, O. Gaide, K. Alevizopoulos, and J. Tschopp, NF-??B Signals Induce the Expression of c-FLIP, HAL author manuscript inserm-00144897, version 1 HAL author manuscript inserm-00144897, pp.5299-305, 2001.
DOI : 10.1128/MCB.21.16.5299-5305.2001

O. Micheau and J. Tschopp, Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes, Cell, vol.114, issue.2, pp.181-90, 2003.
DOI : 10.1016/S0092-8674(03)00521-X
URL : https://hal.archives-ouvertes.fr/inserm-00527105

Y. Deng, X. Ren, L. Yang, Y. Lin, and X. Wu, A JNK-Dependent Pathway Is Required for TNF??-Induced Apoptosis, Cell, vol.115, issue.1, pp.61-70, 2003.
DOI : 10.1016/S0092-8674(03)00757-8

V. Benoit, C. A. Delacroix, L. Deregowski, V. Jacobs, N. Merville et al., Caspase-8-Dependent HER-2 Cleavage in Response to Tumor Necrosis Factor ?? Stimulation Is Counteracted by Nuclear Factor ??B through c-FLIP-L Expression, Cancer Research, vol.64, issue.8, pp.2684-91, 2004.
DOI : 10.1158/0008-5472.CAN-03-2914

B. Bladergroen, M. Strik, N. Bovenschen, O. Van-berkum, G. Scheffer et al., The Granzyme B Inhibitor, Protease Inhibitor 9, Is Mainly Expressed by Dendritic Cells and at Immune-Privileged Sites, The Journal of Immunology, vol.166, issue.5, pp.3218-3243, 2001.
DOI : 10.4049/jimmunol.166.5.3218

B. Bladergroen, M. Strik, A. Wolbink, D. Wouters, R. Broekhuizen et al., The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells, European Journal of Immunology, vol.141, issue.4, pp.1175-83, 2005.
DOI : 10.1002/eji.200425949

B. Bladergroen, C. Meijer, R. Ten-berge, C. Hack, J. Muris et al., Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?, Blood, vol.99, issue.1, pp.232-239, 2002.
DOI : 10.1182/blood.V99.1.232

W. Pear, J. Miller, L. Xu, J. Pui, B. Soffer et al., Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abltransduced bone marrow, Blood, vol.92, issue.2410, pp.3780-92, 1998.

Y. Soneoka, P. Cannon, E. Ramsdale, J. Griffiths, G. Romano et al., A transient three-plasmid expression system for the production of high titer retroviral vectors, Nucleic Acids Research, vol.23, issue.4, pp.628-661, 1995.
DOI : 10.1093/nar/23.4.628

P. Gettins, Serpin Structure, Mechanism, and Function, Chemical Reviews, vol.102, issue.12, pp.4751-804, 2002.
DOI : 10.1021/cr010170+

J. Dickinson, E. Bates, A. Ferrante, and T. Antalis, Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function, J Biol Chem Nov, vol.17270, issue.2746, pp.27894-904, 1995.

R. Schleef and T. Chuang, Protease Inhibitor 10 Inhibits Tumor Necrosis Factor alpha -induced Cell Death. EVIDENCE FOR THE FORMATION OF INTRACELLULAR HIGH Mr PROTEASE INHIBITOR 10-CONTAINING COMPLEXES, Journal of Biological Chemistry, vol.275, issue.34, pp.26385-26394, 2000.
DOI : 10.1074/jbc.C000389200

Y. Suminami, S. Nagashima, N. Vujanovic, K. Hirabayashi, H. Kato et al., Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1, British Journal of Cancer, vol.82, issue.4, pp.981-990, 2000.
DOI : 10.1054/bjoc.1999.1028

O. Micheau, M. Thome, P. Schneider, N. Holler, J. Tschopp et al., The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex, Journal of Biological Chemistry, vol.277, issue.47, pp.45162-71, 2002.
DOI : 10.1074/jbc.M206882200

A. Krueger, I. Schmitz, S. Baumann, P. Krammer, and S. Kirchhoff, Cellular FLICE-inhibitory Protein Splice Variants Inhibit Different Steps of Caspase-8 Activation at the CD95 Death-inducing Signaling Complex, Journal of Biological Chemistry, vol.276, issue.23, pp.20633-20673, 2001.
DOI : 10.1074/jbc.M101780200

J. Huntington, R. Read, and R. Carrell, Structure of a serpin-protease complex shows inhibition by deformation, Nature, vol.407, issue.6806, pp.923-929, 2000.
DOI : 10.1038/35038119

R. Ziccardi and N. Cooper, Active disassembly of the first complement component, C-1, by C-1 inactivator, J Immunol, vol.123, issue.2, pp.788-92, 1979.

M. Sprick, E. Rieser, H. Stahl, A. Grosse-wilde, M. Weigand et al., Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8, The EMBO Journal, vol.21, issue.17, pp.4520-4550, 2002.
DOI : 10.1093/emboj/cdf441

J. Oudejans, H. Harijadi, J. Kummer, I. Tan, E. Bloemena et al., High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent, The Journal of Pathology, vol.194, issue.4, pp.468-75, 2002.
DOI : 10.1002/path.1236

J. Medema, J. De-jong, L. Peltenburg, E. Verdegaal, A. Gorter et al., Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors, Proceedings of the National Academy of Sciences, vol.98, issue.20, pp.11515-11535, 2001.
DOI : 10.1073/pnas.201398198

I. Van-houdt, J. Oudejans, A. Van-den-eertwegh, A. Baars, W. Vos et al., Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma, Clinical Cancer Research, vol.11, issue.17, pp.6400-6407, 2005.
DOI : 10.1158/1078-0432.CCR-05-0306

R. Ten-berge, C. Meijer, D. Dukers, J. Kummer, B. Bladergroen et al., Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma, Blood, vol.99, issue.12, pp.4540-4546, 2002.
DOI : 10.1182/blood.V99.12.4540